TEAS Plus New Application

HAVESTUS

Glaxo Group Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88507992
Filing Date: 07/10/2019

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK HAVESTUS
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT HAVESTUS
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Glaxo Group Limited
*STREET 980 Great West Road
*CITY Brentford, Middlesex
*COUNTRY United Kingdom
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
TW89GS
EMAIL ADDRESS trademarks@gsk.com
LEGAL ENTITY INFORMATION
*TYPE private company limited by shares (prc)
* STATE/COUNTRY WHERE LEGALLY ORGANIZED England
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Merilee J. Arevalo
ATTORNEY DOCKET NUMBER 82796210
FIRM NAME GSK
INTERNAL ADDRESS LBP, 5.5A
STREET 5 Moore Drive
CITY Research Triangle Park
STATE North Carolina
COUNTRY United States
ZIP/POSTAL CODE 27709-3398
PHONE 919-315-8204
FAX 919-315-3023
EMAIL ADDRESS trademarks@gsk.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Christopher M Hanes and Terence A Dixon
CORRESPONDENCE INFORMATION
*NAME Merilee J. Arevalo
FIRM NAME GSK
INTERNAL ADDRESS LBP, 5.5A
*STREET 5 Moore Drive
*CITY Research Triangle Park
*STATE
(Required for U.S. addresses)
North Carolina
*COUNTRY United States
*ZIP/POSTAL CODE 27709-3398
PHONE 919-315-8204
FAX 919-315-3023
*EMAIL ADDRESS trademarks@gsk.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
FEE PER CLASS 225
*TOTAL FEE PAID 225
SIGNATURE INFORMATION
* SIGNATURE /Merilee J. Arevalo/
* SIGNATORY'S NAME Merilee J. Arevalo
* SIGNATORY'S POSITION Trademark Counsel, NJ and PA bar member
SIGNATORY'S PHONE NUMBER 919-315-8204
* DATE SIGNED 07/10/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88507992
Filing Date: 07/10/2019

To the Commissioner for Trademarks:

MARK: HAVESTUS (Standard Characters, see mark)
The mark in your application is HAVESTUS.


The applicant, Glaxo Group Limited, a private company limited by shares (prc) legally organized under the laws of England, having an address of
      980 Great West Road
      Brentford, Middlesex TW89GS
      United Kingdom
      trademarks@gsk.com (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
       International Class 005:  Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).



The applicant's current Attorney Information:
      Merilee J. Arevalo and Christopher M Hanes and Terence A Dixon of GSK
      LBP, 5.5A
      5 Moore Drive
      Research Triangle Park, North Carolina 27709-3398
      United States
      919-315-8204(phone)
      919-315-3023(fax)
      trademarks@gsk.com (authorized)
The attorney docket/reference number is 82796210.
The applicant's current Correspondence Information:
      Merilee J. Arevalo
      GSK
      LBP, 5.5A
      5 Moore Drive
      Research Triangle Park, North Carolina 27709-3398
      919-315-8204(phone)
      919-315-3023(fax)
      trademarks@gsk.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Merilee J. Arevalo/   Date: 07/10/2019
Signatory's Name: Merilee J. Arevalo
Signatory's Position: Trademark Counsel, NJ and PA bar member
Signatory's Phone Number: 919-315-8204
Payment Sale Number: 88507992
Payment Accounting Date: 07/11/2019

Serial Number: 88507992
Internet Transmission Date: Wed Jul 10 15:59:44 EDT 2019
TEAS Stamp: USPTO/FTK-XXX.XX.XX.X-201907101559448375
35-88507992-620a26069c536859088f83acb0e0
1bf7bd66f922ce9e3b217cf3b9812c5f6db-DA-2
552-20190710140646105997

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed